Sheila López-Cobo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sheila López-Cobo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ariane Biquand
Mnemo Therapeutics, Paris, France
17 shared publications - Armelle Bohineust
Mnemo Therapeutics, Paris, France
17 shared publications - Christel Goudot
Institut Curie, PSL Research University, INSERM, U932, Paris, France
17 shared publications - Franck Perez
Institut Curie, PSL Research University, Paris, France
17 shared publications - Irena Chacón
Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France
17 shared publications - Jaime R. Fuentealba
Institut Curie
17 shared publications
Latest Publications
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell ATAC-seq. Related to Figures 5 and S7.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell ATAC-seq. Related to Figures 5 and S7.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
List of OFF-target sites for Suv-1 gRNA. Differentially expressed genes between mock and gSUV CD8+ T cells by Nanostring. Related to Figures 1 and S1, S2.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
List of OFF-target sites for Suv-1 gRNA. Differentially expressed genes between mock and gSUV CD8+ T cells by Nanostring. Related to Figures 1 and S1, S2.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Gene signatures used in the study. Related to Figures 3, 4, 5, S4, S5, S6, and S7.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Gene signatures used in the study. Related to Figures 3, 4, 5, S4, S5, S6, and S7.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Gene signatures used in the study. Related to Figures 3, 4, 5, S4, S5, S6, and S7.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Gene signatures used in the study. Related to Figures 3, 4, 5, S4, S5, S6, and S7.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S8 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Supplementary Figures and Legends, Supplementary Table Legends Supplementary Figure S1.Engineering SUV39H1-deficient human T cells. Supplementary Figure S2. SUV39H1-deficient T cells show enhanced stem/memory and less effector/exhausted phenotype. Supplementary Figure S3. SUV39H1 deletion in CAR T cells promotes stronger rejection of liquid and solid tumors. Supplementary Figure S4. Single-cell transcriptomics reveals enrichment of stem/memory cells and signatures in SUV39H1-deficient CAR T cells. Supplementary Figure S5. Enhanced self-renewal in SUV39H1-deficient stem/memory populations. Supplementary Figure 6. SUV39H1-deficient memory CAR T cell signature correlates with clinical response. Supplementary Figure 7. SUV39H1 ablation induces chromatin opening at stem/memory loci in all CAR T cell subpopulations. Supplementary Figure 8. SUV39H1-deficient BBz-CAR T cells show stronger memory persistence and mediate long-term protection against tumor rechallenge.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S8 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Supplementary Figures and Legends, Supplementary Table Legends Supplementary Figure S1.Engineering SUV39H1-deficient human T cells. Supplementary Figure S2. SUV39H1-deficient T cells show enhanced stem/memory and less effector/exhausted phenotype. Supplementary Figure S3. SUV39H1 deletion in CAR T cells promotes stronger rejection of liquid and solid tumors. Supplementary Figure S4. Single-cell transcriptomics reveals enrichment of stem/memory cells and signatures in SUV39H1-deficient CAR T cells. Supplementary Figure S5. Enhanced self-renewal in SUV39H1-deficient stem/memory populations. Supplementary Figure 6. SUV39H1-deficient memory CAR T cell signature correlates with clinical response. Supplementary Figure 7. SUV39H1 ablation induces chromatin opening at stem/memory loci in all CAR T cell subpopulations. Supplementary Figure 8. SUV39H1-deficient BBz-CAR T cells show stronger memory persistence and mediate long-term protection against tumor rechallenge.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S8 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Supplementary Figures and Legends, Supplementary Table Legends Supplementary Figure S1.Engineering SUV39H1-deficient human T cells. Supplementary Figure S2. SUV39H1-deficient T cells show enhanced stem/memory and less effector/exhausted phenotype. Supplementary Figure S3. SUV39H1 deletion in CAR T cells promotes stronger rejection of liquid and solid tumors. Supplementary Figure S4. Single-cell transcriptomics reveals enrichment of stem/memory cells and signatures in SUV39H1-deficient CAR T cells. Supplementary Figure S5. Enhanced self-renewal in SUV39H1-deficient stem/memory populations. Supplementary Figure 6. SUV39H1-deficient memory CAR T cell signature correlates with clinical response. Supplementary Figure 7. SUV39H1 ablation induces chromatin opening at stem/memory loci in all CAR T cell subpopulations. Supplementary Figure 8. SUV39H1-deficient BBz-CAR T cells show stronger memory persistence and mediate long-term protection against tumor rechallenge.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S8 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Supplementary Figures and Legends, Supplementary Table Legends Supplementary Figure S1.Engineering SUV39H1-deficient human T cells. Supplementary Figure S2. SUV39H1-deficient T cells show enhanced stem/memory and less effector/exhausted phenotype. Supplementary Figure S3. SUV39H1 deletion in CAR T cells promotes stronger rejection of liquid and solid tumors. Supplementary Figure S4. Single-cell transcriptomics reveals enrichment of stem/memory cells and signatures in SUV39H1-deficient CAR T cells. Supplementary Figure S5. Enhanced self-renewal in SUV39H1-deficient stem/memory populations. Supplementary Figure 6. SUV39H1-deficient memory CAR T cell signature correlates with clinical response. Supplementary Figure 7. SUV39H1 ablation induces chromatin opening at stem/memory loci in all CAR T cell subpopulations. Supplementary Figure 8. SUV39H1-deficient BBz-CAR T cells show stronger memory persistence and mediate long-term protection against tumor rechallenge.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell RNA-seq and identification genes used for cluster definitions. Related to Figures 3 and S4.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell RNA-seq and identification genes used for cluster definitions. Related to Figures 3 and S4.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Differentially expressed genes between mock and gSUV clusters in CD8+ and CD4+ T cells. Related to Figures 3, 4, S4, S5.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Differentially expressed genes between mock and gSUV clusters in CD8+ and CD4+ T cells. Related to Figures 3, 4, S4, S5.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Reagents or resources used in the study. Numbers of donors and CAR-T productions for in vitro experiments. Donor information for in vivo experiments.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Reagents or resources used in the study. Numbers of donors and CAR-T productions for in vitro experiments. Donor information for in vivo experiments.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell RNA-seq and identification genes used for cluster definitions. Related to Figures 3 and S4.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
Numbers of cells analyzed by single-cell RNA-seq and identification genes used for cluster definitions. Related to Figures 3 and S4.